Scandinavian Biolabs ApS: Financial statements 2023
CVR: 41170514
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Scandinavian Biolabs ApS (CVR 41170514) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 5,145,086 and a net result of DKK -1,353,556 compared with DKK -2,515,828 the year before. That is an increase of 223.4% compared with the year before. Equity in the 2023 report amounted to DKK -1,283,922. The company had 22 employees in the financial year.
- Gross Profit
- DKK 5,145,086
- Profit/Loss
- DKK -1,353,556
- Equity
- DKK -1,283,922
- Total Assets
- DKK 11,348,329
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 5.1M | -1.4M | -1.3M | 22 |
| 2022 | - | 1.6M | -2.5M | -5.9M | 19 |
| 2021 | - | -1.9M | -4.6M | -3.4M | 12 |
| 2020 | - | -1.1M | -1.8M | -1.7M | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Scandinavian Biolabs ApS has published its annual report for 2022. Gross profit came to DKK 1,591,104, and the net result was DKK -2,515,828.
About Scandinavian Biolabs ApS
Scandinavian Biolabs ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Engroshandel med parfumerivarer og kosmetik. The management consists of Niels Valdemar Lundsgaard Konradi. The board consists of Mitesh Jatania (chair), Anders Reckendorff, Pascar Paw Paramasivam and Samuel Meeker Kaplan. The company's owners include Niels Valdemar Lundsgaard Konradi, Anders Reckendorff and BLAZAR ApS. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -13,841,560 and a net result of DKK -25,270,973 compared with DKK -8,773,342 the year before. Equity in the 2025 report amounted to DKK 31,549,921.